MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/03936155241296164

Медицинская библиотека · The International journal of biological markers · 2024

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.

Indraccolo Stefano, Signoriello Simona, Piga Ilaria, Esposito Giovanni, Ferrarini Federica, Boscolo Bragadin Andrea, Salutari Vanda, Pisano Carmela, Califano Daniela, Bignotti Eliana, Tognon Germana, Simeon Vittorio, Artioli Grazia, Ferrero Annamaria, Cinieri Saverio, Bologna Alessandra, Chiodini Paolo, Scognamiglio Giosuè, Bottoni Carolina, Spina Anna, Russo Daniela, Arenare Laura, Perrone Francesco, Pignata Sandro

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

In ovarian cancer, expression of metabolism-related markers has been investigated in several studies focusing on individual markers; however, a parallel quantitative evaluation of markers mapping to distinct metabolic processes and their prognostic value in large patient cohorts is still lacking.

METHODS

Here, by using immunohistochemistry followed by digital pathology, we investigated the expression of several markers related to glycolysis including monocarboxylate transporter 1 and 4 (MCT1, MCT4), glutamine metabolism (glutaminase, GLS) and hypoxia/acidosis (carbonic anhydrase 9, CA IX) in tissue microarrays of > 300 patients recruited in the MITO16A clinical trial, which involved treatment of ovarian cancer patients with carboplatin/taxol plus bevacizumab.

RESULTS

Regarding the prognostic impact of these markers, results indicate that GLS expression correlated with progression-free survival, but this effect disappeared when data were corrected for multiple testing. All other markers showed no correlation with clinical outcome.

CONCLUSION

These results indicate marked heterogeneity of expression of metabolism-associated markers in ovarian cancer; however, there was a lack of association with clinical benefit after chemotherapy/anti-vascular endothelial growth factor treatment. Notwithstanding the lack of prognostic value, knowledge of the pattern of expression of these biomarkers in tumors can be useful for patient stratification purposes when new drugs targeting these metabolic pathways will be tested.

Для цитирования: Indraccolo Stefano, Signoriello Simona, Piga Ilaria, Esposito Giovanni, Ferrarini Federica, Boscolo Bragadin Andrea, Salutari Vanda, Pisano Carmela, Califano Daniela, Bignotti Eliana, Tognon Germana, Simeon Vittorio, Artioli Grazia, Ferrero Annamaria, Cinieri Saverio, Bologna Alessandra, Chiodini Paolo, Scognamiglio Giosuè, Bottoni Carolina, Spina Anna, Russo Daniela, Arenare Laura, Perrone Francesco, Pignata Sandro. Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.. The International journal of biological markers. 2024. DOI: 10.1177/03936155241296164.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.